DE69635612D1 - DETECTION AND AMPLIFICATION OF NUCLEIC ACIDS BY CHEMICAL COMPOUND OF OLIGONUCLEOTIDES - Google Patents

DETECTION AND AMPLIFICATION OF NUCLEIC ACIDS BY CHEMICAL COMPOUND OF OLIGONUCLEOTIDES

Info

Publication number
DE69635612D1
DE69635612D1 DE69635612T DE69635612T DE69635612D1 DE 69635612 D1 DE69635612 D1 DE 69635612D1 DE 69635612 T DE69635612 T DE 69635612T DE 69635612 T DE69635612 T DE 69635612T DE 69635612 D1 DE69635612 D1 DE 69635612D1
Authority
DE
Germany
Prior art keywords
oligonucleotides
amplification
detection
nucleic acids
chemical compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635612T
Other languages
German (de)
Other versions
DE69635612T2 (en
Inventor
David Segev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Publication of DE69635612D1 publication Critical patent/DE69635612D1/en
Application granted granted Critical
Publication of DE69635612T2 publication Critical patent/DE69635612T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69635612T 1995-05-01 1996-04-30 DETECTION AND AMPLIFICATION OF NUCLEIC ACIDS BY CHEMICAL COMPOUND OF OLIGONUCLEOTIDES Expired - Fee Related DE69635612T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US431527 1995-05-01
US08/431,527 US5843650A (en) 1995-05-01 1995-05-01 Nucleic acid detection and amplification by chemical linkage of oligonucleotides
PCT/US1996/006042 WO1996034984A1 (en) 1995-05-01 1996-04-30 Nucleic acid detection and amplification by chemical linkage of oligonucleotides

Publications (2)

Publication Number Publication Date
DE69635612D1 true DE69635612D1 (en) 2006-01-26
DE69635612T2 DE69635612T2 (en) 2006-10-19

Family

ID=23712327

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635612T Expired - Fee Related DE69635612T2 (en) 1995-05-01 1996-04-30 DETECTION AND AMPLIFICATION OF NUCLEIC ACIDS BY CHEMICAL COMPOUND OF OLIGONUCLEOTIDES

Country Status (7)

Country Link
US (1) US5843650A (en)
EP (1) EP0828856B1 (en)
JP (1) JP4216333B2 (en)
AU (1) AU5918396A (en)
CA (1) CA2217325C (en)
DE (1) DE69635612T2 (en)
WO (1) WO1996034984A1 (en)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767259A (en) 1994-12-27 1998-06-16 Naxcor Oligonucleotides containing base-free linking groups with photoactivatable side chains
WO1998030575A1 (en) * 1997-01-08 1998-07-16 Proligo Llc Bioconjugation of macromolecules
US20030165888A1 (en) * 2001-07-18 2003-09-04 Brown Bob D. Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
US6518017B1 (en) 1997-10-02 2003-02-11 Oasis Biosciences Incorporated Combinatorial antisense library
US7427678B2 (en) 1998-01-08 2008-09-23 Sigma-Aldrich Co. Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
CA2319662C (en) * 1998-01-27 2009-11-24 Cytocell Limited Modified nucleic acid probes and uses thereof
JP2002524091A (en) 1998-08-21 2002-08-06 ナックスコー・インコーポレイテッド Assays using immobilized crosslinkable nucleic acids
US6303799B1 (en) 1998-11-10 2001-10-16 Naxcor Polynucleotide crosslinking agents
GB9825687D0 (en) * 1998-11-25 1999-01-20 Link Technologies Ltd Oligonucleotide conjugation
CA2365984A1 (en) * 1999-04-08 2000-10-19 Oasis Biosciences, Inc. Antisense oligonucleotides comprising universal and/or degenerate bases
DK1471926T3 (en) 1999-06-01 2011-02-28 Baylor College Medicine Compositions and Methods for Therapeutic Use of an Atonal-Associated Sequence
US6200781B1 (en) 1999-06-25 2001-03-13 Integrated Genetic Devices, Ltd. Apparatus, system and method for automated execution and analysis of biological and chemical reactions
US6290831B1 (en) 1999-08-30 2001-09-18 Integrated Genetic Devices, Ltd. Electrophoretic system for real time detection of multiple electrophoresed biopolymers
EP1261857A1 (en) * 2000-03-06 2002-12-04 The Johns Hopkins University Scatter controlled emission for optical taggants and chemical sensors
US6528318B1 (en) 2000-03-06 2003-03-04 The Johns Hopkins University Scatter controlled emission for optical taggants and chemical sensors
US6573048B1 (en) * 2000-04-18 2003-06-03 Naxcor Degradable nucleic acid probes and nucleic acid detection methods
US20040067498A1 (en) * 2000-04-28 2004-04-08 Ahmed Chenna Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
EP1401850A1 (en) 2001-06-20 2004-03-31 Nuevolution A/S Nucleoside derivatives for library preparation
CA2451498A1 (en) * 2001-06-22 2003-01-03 Marshfield Clinic Methods and oligonucleotides for the detection of salmonella sp., e. coli o157:h7, and listeria monocytogenes
DE10147074A1 (en) * 2001-09-25 2003-05-08 Beru Ag Method for operating a multi-stage electric heater consisting of several heating elements
AU2002360344A1 (en) * 2001-11-09 2003-05-26 Monogram Biosciences, Inc. Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
DE20200926U1 (en) * 2002-01-23 2002-04-18 Hegenscheidt Mfd Gmbh & Co Kg Deep rolling device of a deep rolling machine for crankshafts
WO2003062452A2 (en) 2002-01-23 2003-07-31 Proligo, Llc Methods for the integrated synthesis and purification of oligonucleotides
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
WO2003064625A2 (en) 2002-02-01 2003-08-07 Sequitur, Inc. Oligonucleotide compositions with enhanced efficiency
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
AU2003214033A1 (en) * 2002-03-15 2003-09-29 Nuevolution A/S A building block capable of transferring a functional entity
WO2003078446A2 (en) * 2002-03-15 2003-09-25 Nuevolution A/S A building block forming a c-c or a c-hetero atom bond upon reaction
WO2003078050A2 (en) * 2002-03-15 2003-09-25 Nuevolution A/S A building block forming a c-c bond upon reaction
IL163822A0 (en) * 2002-03-15 2005-12-18 Nuevolution As An improved method for synthesising templated molecules
US7211382B2 (en) * 2002-04-09 2007-05-01 Orchid Cellmark Inc. Primer extension using modified nucleotides
US6916474B2 (en) 2002-07-15 2005-07-12 Board Of Regents, The University Of Texas System Antibodies with increased affinities for anthrax antigens
WO2004013070A2 (en) 2002-08-01 2004-02-12 Nuevolution A/S Multi-step synthesis of templated molecules
CN101912421A (en) 2002-08-12 2010-12-15 杰能斯有限公司 Methods and compositions concerning poxviruses and cancer
WO2004039825A2 (en) 2002-10-30 2004-05-13 Nuevolution A/S Method for the synthesis of a bifunctional complex
AU2003291964A1 (en) * 2002-12-19 2004-07-14 Nuevolution A/S Quasirandom structure and function guided synthesis methods
AU2002361255A1 (en) 2002-12-31 2004-07-22 Proligo Llc Methods and compositions for the tandem synthesis of two or more oligonuleotides on the same solid support
EP1597394A2 (en) * 2003-02-21 2005-11-23 Nuevolution A/S A method for obtaining structural information about an encoded molecule
WO2004074429A2 (en) * 2003-02-21 2004-09-02 Nuevolution A/S Method for producing second-generation library
ATE424455T1 (en) * 2003-03-20 2009-03-15 Nuevolution As LIGATION-MEDIATING CODING OF SMALL MOLECULES
JP4782668B2 (en) 2003-03-31 2011-09-28 エフ．ホフマン−ラ ロシュ アーゲー Compositions and methods for detecting certain flaviviruses, including members of the Japanese encephalitis virus serogroup
FR2855269B1 (en) * 2003-05-21 2007-06-08 Commissariat Energie Atomique DEVICE AND METHODS FOR HANGING / REMOVING A TARGET OR OBJECT PRESENT IN A SAMPLE
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
EP2295569A1 (en) 2003-07-25 2011-03-16 Ambion, Inc. Methods and compositions for preparing rna from a fixed sample
US7087437B2 (en) * 2003-09-16 2006-08-08 Vici Gig Harbor Group, Inc. Direct vial surface sorbent micro extraction device and method
EP1670939B1 (en) 2003-09-18 2009-11-04 Nuevolution A/S A method for obtaining structural information concerning an encoded molecule and method for selecting compounds
US7704925B2 (en) * 2004-03-22 2010-04-27 Nuevolution A/S Ligational encoding using building block oligonucleotides
EP1802775B1 (en) 2004-09-14 2010-05-26 The Regents of the University of Colorado Method for treatment with bucindolol based on genetic targeting
US20060240442A1 (en) * 2005-04-20 2006-10-26 Vevea Dirk N Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes
US20060246463A1 (en) * 2005-04-20 2006-11-02 Vevea Dirk N Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes
MX2007013296A (en) 2005-05-02 2007-12-13 Basf Ag New labelling strategies for the sensitive detection of analytes.
KR101335218B1 (en) 2005-05-02 2013-12-12 바스프 에스이 New labelling strategies for the sensitive detection of analytes
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
WO2007030668A2 (en) 2005-09-07 2007-03-15 Jennerex Biotherapeutics Ulc Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
WO2007120192A2 (en) 2005-10-27 2007-10-25 The President And Fellows Of Harvard College Methods and compositions for labeling nucleic acids
LT2336315T (en) 2005-12-01 2017-11-10 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
CA2637598A1 (en) 2006-01-18 2007-02-14 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
US8114636B2 (en) 2006-02-10 2012-02-14 Life Technologies Corporation Labeling and detection of nucleic acids
EP3438131B1 (en) 2006-02-10 2022-03-16 Life Technologies Corporation Oligosaccharide modification and labeling of proteins
CA2663034C (en) 2006-09-15 2016-05-03 Ottawa Health Research Institute Oncolytic rhabdovirus
PT2089343E (en) 2006-10-31 2011-09-06 Baseclick Gmbh Click chemistry for the production of reporter molecules
ATE555128T1 (en) 2006-11-30 2012-05-15 Res Dev Foundation IMPROVED IMMUNOLOBULIN LIBRARIES
AU2008237018B2 (en) * 2007-04-10 2014-04-03 Nanostring Technologies, Inc. Methods and computer systems for identifying target-specific sequences for use in nanoreporters
DK2155789T3 (en) 2007-05-01 2013-10-21 Res Dev Foundation Immunoglobulin Fc libraries
CA2701726A1 (en) * 2007-10-04 2009-04-09 Halcyon Molecular Sequencing nucleic acid polymers with electron microscopy
JP5498952B2 (en) 2007-11-21 2014-05-21 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド Process for reacting alkynes with alkynes and 1,3-dipolar functional compounds
CN102119223A (en) 2008-05-16 2011-07-06 生命技术公司 Dual labeling methods for measuring cellular proliferation
WO2010042481A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial eap, emp, and/or adsa proteins
KR20170102039A (en) 2009-04-03 2017-09-06 유니버시티 오브 시카고 Compositions and methods related to Protein A (SpA) variants
EP2789689B1 (en) 2009-06-29 2016-04-27 Luminex Corporation Chimeric primers with hairpin conformations and methods of using same
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
US9512481B2 (en) 2009-09-11 2016-12-06 The Regents Of The University Of Colorado, A Body Corporate Polymorphisms in the PDE3A gene
CA2774144C (en) 2009-09-14 2018-02-13 Jennerex, Inc. Oncolytic vaccinia virus combination cancer therapy
CN102858959B (en) 2009-12-10 2016-02-24 渥太华医院研究院 Oncolytic rhabdovirus
CA2822747A1 (en) 2009-12-23 2011-06-30 Arca Biopharma, Inc. Use of s-(6-nitro-oxi-hexahydro-furo[3,2-b]thioacetate in the treatment of cardiovascular disorders associated with oxide synthase dysfunction
US8808699B2 (en) 2010-04-05 2014-08-19 The University Of Chicago Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
SI2558577T1 (en) 2010-04-16 2019-05-31 Nuevolution A/S Bi-functional complexes and methods for making and using such complexes
AU2011274367B2 (en) 2010-07-02 2015-04-23 The University Of Chicago Compositions and methods related to protein A (SpA) variants
WO2012034067A1 (en) 2010-09-09 2012-03-15 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
BR112013017096A2 (en) 2011-01-04 2020-09-01 Jennerex Inc. composition and methods of inducing complement-dependent cytotoxic response mediated by tumor specific antibody in animal having tumor, in vivo antibody generation, inhibiting cancer cell growth or death, to treat individual with cancer, to adapt to therapy of cancer for individual with cancer and to identify tumor specific antigen
CA2826467C (en) 2011-02-07 2019-11-12 Research Development Foundation Engineered immunoglobulin fc polypeptides
US20140057295A1 (en) 2011-02-28 2014-02-27 Barbara J. Stegmann Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
AU2012226530B2 (en) 2011-03-08 2016-12-01 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
US9085631B2 (en) 2011-04-08 2015-07-21 Nov Vac APS Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
WO2012167382A1 (en) 2011-06-08 2012-12-13 Children's Hospital Of Eastern Ontario Research Institute Inc. Compositions and methods for glioblastoma treatment
US10040853B2 (en) 2011-09-09 2018-08-07 Fred Hutchinson Cancer Research Center Methods and compositions involving NKG2D inhibitors and cancer
EP2766388A1 (en) 2011-10-12 2014-08-20 Møller, Niels Iversen Peptides derived from campylobacter jejuni and their use in vaccination
ES2645418T3 (en) 2011-12-22 2017-12-05 Ibis Biosciences, Inc. Amplification of a sequence of a ribonucleic acid
WO2013116698A2 (en) 2012-02-02 2013-08-08 Invenra, Inc. High throughput screen for biologically active polypeptides
NZ702285A (en) 2012-04-26 2016-07-29 Univ Chicago Staphylococcal coagulase antigens and methods of their use
CN104769134A (en) 2012-09-11 2015-07-08 赛拉诺斯股份有限公司 Information management systems and methods using a biological signature
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
RU2684211C2 (en) 2013-02-21 2019-04-04 Тёрнстоун Лимитед Партнершип Vaccine composition
BR112016007391A2 (en) 2013-10-03 2017-08-01 Oklahoma Med Res Found biomarkers of activity, intensity and acute phase of systemic lupus erythematosus disease
EP3077820A1 (en) 2013-12-03 2016-10-12 Evaxion Biotech ApS Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
EP3777883A1 (en) 2014-11-13 2021-02-17 Evaxion Biotech ApS Peptides derived from acinetobacter baumannii and their use in vaccination
US20180057839A1 (en) 2014-11-26 2018-03-01 The Regents Of The University Of California Therapeutic compositions comprising transcription factors and methods of making and using the same
ES2957554T3 (en) 2015-01-12 2024-01-22 Evaxion Biotech Aps Treatment and prophylaxis of K. pneumoniae infection
CA2976236A1 (en) 2015-02-09 2016-08-18 Research Development Foundation Engineered immunoglobulin fc polypeptides displaying improved complement activation
EP3070178B1 (en) 2015-03-20 2020-02-12 Albert-Ludwigs-Universität Freiburg Method for diagnosing breast cancer
WO2017005670A1 (en) 2015-07-04 2017-01-12 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
US10526408B2 (en) 2015-08-28 2020-01-07 Research Development Foundation Engineered antibody FC variants
EP3419654B1 (en) 2016-02-22 2022-04-27 Evaxion Biotech A/S Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
EP3565576A1 (en) 2017-01-05 2019-11-13 Evaxion Biotech ApS Vaccines targeting pseudomonas aeruginosa
US20190390278A1 (en) 2017-01-26 2019-12-26 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
CA3116539C (en) 2018-10-18 2023-10-03 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
WO2020083904A1 (en) 2018-10-22 2020-04-30 Evaxion Biotech Aps Vaccines targeting m. catharrhalis
WO2020174044A1 (en) 2019-02-27 2020-09-03 Evaxion Biotech Aps Vaccines targeting h. influenzae
ES2960366T3 (en) 2019-08-09 2024-03-04 Univ Freiburg Albert Ludwigs Method to diagnose breast cancer
US20230050225A1 (en) 2020-01-06 2023-02-16 Evaxion Biotech A/S Vaccines targeting Neisseria gonorrhoeae
WO2023239940A1 (en) 2022-06-10 2023-12-14 Research Development Foundation Engineered fcriib selective igg1 fc variants and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5185243A (en) * 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
CA2039517C (en) * 1990-04-03 2006-11-07 David Segev Dna probe signal amplification
HU218095B (en) * 1990-05-01 2000-05-28 Amgen Inc. Process for reducing transitional contaminations in amplification processes
US5424413A (en) * 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
US5846709A (en) * 1993-06-15 1998-12-08 Imclone Systems Incorporated Chemical process for amplifying and detecting nucleic acid sequences

Also Published As

Publication number Publication date
JP4216333B2 (en) 2009-01-28
AU5918396A (en) 1996-11-21
CA2217325C (en) 2007-11-27
EP0828856A1 (en) 1998-03-18
EP0828856B1 (en) 2005-12-21
US5843650A (en) 1998-12-01
CA2217325A1 (en) 1996-11-07
DE69635612T2 (en) 2006-10-19
EP0828856A4 (en) 2001-11-21
JPH11504517A (en) 1999-04-27
WO1996034984A1 (en) 1996-11-07

Similar Documents

Publication Publication Date Title
DE69635612D1 (en) DETECTION AND AMPLIFICATION OF NUCLEIC ACIDS BY CHEMICAL COMPOUND OF OLIGONUCLEOTIDES
DE69636843D1 (en) Detection of nucleic acid changes
DE69836885D1 (en) Detection of nucleic acids by fluorescence quenching
DE69330834D1 (en) QUANTITATIVE DETECTION OF MACROMOLECULES WITH THE AID OF FLUORESCENT OLIGONUCLEOTIDES
DE69426956T2 (en) Detection of mycobacteria by nucleic acid multiplex amplification
DE69528670D1 (en) DETECTION OF NUCLEIC ACIDS BY NUCLEASE-CATALYZED PRODUCT PRODUCTION
FR2715847B1 (en) Composition containing nucleic acids, preparation and uses.
DE69424151D1 (en) AUTOMATED SYNTHESIS OF OLIGONUCLEOTIDES
DE69935314D1 (en) Quantitative Determination of Nucleic Acid Amplification Products
DE69431719D1 (en) HYBRIDIZATION AND SEQUENCING OF NUCLEIC ACIDS
DE69637518D1 (en) Homogenous duplication and detection of nucleic acids
DE69637065D1 (en) The determination of nucleic acids and nucleic acid units
DE69627122D1 (en) Detection of polymorphism
DE69620903T2 (en) DETECTION OF NUCLEIC ACIDS BY TEMPLATE-DEPENDENT PRODUCT
CA2159103A1 (en) Detection of human immunodeficiency virus type 1
DE69813986D1 (en) PREPARATION OF PARTICLES BY A CHEMICAL RESPONSE
DE69325104T2 (en) PAPER PRODUCTS CONTAINING CHEMICAL SOFTENERS
DE69633941D1 (en) DETECTION OF DIFFERENCES IN NUCLEIC ACIDS
DE69821973D1 (en) CHEMICAL CHANGE OF ELECTROCHEMICALLY ACTIVATED WATER
DE69331996D1 (en) Chemical analysis by electrophoresis
DE69819998D1 (en) Process for the chemical synthesis of oligonucleotides
DE69317502D1 (en) Amplification and detection of nucleic acid material
DE69817110D1 (en) Process for the preparation of condensation products from hydroxy-substituted compounds and glyoxyl reagents
DE69608544D1 (en) Leaching of impurities from used polyester
DE69731646D1 (en) ADMINISTRATION OF NUCLEIC ACID PARTICLES

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee